Lysergic acid diethylamide
- Generic Name
- Lysergic acid diethylamide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H25N3O
- CAS Number
- 50-37-3
- Unique Ingredient Identifier
- 8NA5SWF92O
- Background
Debate continues over the nature and causes of chronic flashbacks. Explanations in terms of LSD physically remaining in the body for months or years after consumption have been discounted by experimental evidence. Some say HPPD is a manifestation of post-traumatic stress disorder, not related to the direct action of LSD on brain chemistry, and varies accordi...
- Associated Conditions
- -
- Associated Therapies
- -
'Tofu-Like' Psychedelic Gets FDA Nod - Mindstate's AI-Designed Therapy To Begin Human Trials
Mindstate Design Labs received FDA and EMA approval for human trials of MSD-001, described as 'psychedelic tofu' for its mild effects. The trials aim to validate the neurotech AI platform, Osmanthus, designed to create tailored altered states of consciousness. CEO Dillan DiNardo envisions using psychedelics as tools to understand and design specific mental states, potentially addressing conditions beyond traditional psychedelic uses.
Cannabis and Hallucinogen Use Among Adults Remained at Historic Highs in 2023
Cannabis and hallucinogen use among adults remained at historic highs in 2023, while cigarette use stayed low. Alcohol use declined among younger adults but increased among older ones. Vaping trends rose, especially among younger adults. Gender differences in cannabis use reversed in younger adults but persisted in older ones. The study highlights the need for research on cannabis and hallucinogens.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath